英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
leim查看　leim　在百度字典中的解释百度英翻中〔查看〕
leim查看　leim　在Google字典中的解释Google英翻中〔查看〕
leim查看　leim　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Neurocrine Biosciences
    Our dedication to discovery remains unwavering after more than 30 years of investigating potential life-changing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders Science is in our DNA—our founders were scientists, and their drive to discover is still felt as we continue to investigate potential treatments for rare diseases and conditions
  • Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology . . .
    About Neurocrine Biosciences Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs
  • Neurocrine Biosciences - Wikipedia
    Neurocrine develops treatments for neurological and endocrine-related diseases and disorders In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD)
  • About — Neurocrine Medical Affairs
    At Neurocrine Biosciences, our purpose is simple: to relieve suffering for people with great needs, but few options We apply our experience and unique insight into the interconnections between brain and body systems to treat complex conditions
  • Neurocrine pays $2. 9B for Soleno, its largest M A deal ever
    Neurocrine Biosciences, forever a possible M A target in the biopharma industry, is making a major acquisition itself
  • Immedica to acquire Neurocrine Group Limited, Neurocrine Biosciences . . .
    Under the terms of the agreement, Immedica will acquire Neurocrine Group Limited for a total consideration of $65 Million payable in cash upon closing The transaction is subject to customary closing conditions and is expected to close in late January 2026
  • Neurocrine Biosciences - LinkedIn
    You Deserve Brave Science | Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs
  • Neurocrine Biosciences, Inc. (NBIX) - Yahoo Finance
    Find the latest Neurocrine Biosciences, Inc (NBIX) stock quote, history, news and other vital information to help you with your stock trading and investing
  • Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising . . . - BioSpace
    While an acquisition is a good exit for Soleno Therapeutics, the company’s acceptance of Neurocrine Biosciences’ $53-per-share offer came as a surprise to Stifel analysts given the potential growth of Vykat XR, approved last year for extreme hunger in patients with Prader-Willi syndrome
  • Neurocrine Biosciences Showcases R D Transformation Driving Innovation . . .
    About Neurocrine Biosciences Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs





中文字典-英文字典  2005-2009